136 related articles for article (PubMed ID: 35503261)
21. Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior.
Tsuda Y; Dickson BC; Swanson D; Sung YS; Zhang L; Meyers P; Healey JH; Antonescu CR
Genes Chromosomes Cancer; 2020 May; 59(5):286-294. PubMed ID: 31756779
[TBL] [Abstract][Full Text] [Related]
22. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene].
Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351
[TBL] [Abstract][Full Text] [Related]
23. Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS).
Ichikawa H; Shimizu K; Katsu R; Ohki M
Mol Cell Biol; 1999 Nov; 19(11):7639-50. PubMed ID: 10523652
[TBL] [Abstract][Full Text] [Related]
24. Unusual type of TLS/FUS-ERG chimeric transcript in a pediatric acute myelocytic leukemia with 47,XX,+10,t(16;21)(p11;q22).
Choi HW; Shin MG; Sawyer JR; Cho D; Kee SJ; Baek HJ; Kook H; Kim HJ; Shin JH; Suh SP; Hwang TJ; Ryang DW
Cancer Genet Cytogenet; 2006 Jun; 167(2):172-6. PubMed ID: 16737920
[TBL] [Abstract][Full Text] [Related]
25. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
[TBL] [Abstract][Full Text] [Related]
26. RUNX1 mutation associated with clonal evolution in relapsed pediatric acute myeloid leukemia with t(16;21)(p11;q22).
Ismael O; Shimada A; Elmahdi S; Elshazley M; Muramatsu H; Hama A; Takahashi Y; Yamada M; Yamashita Y; Horide K; Kojima S
Int J Hematol; 2014 Feb; 99(2):169-74. PubMed ID: 24374719
[TBL] [Abstract][Full Text] [Related]
27. Multiplex fusion gene testing in pediatric acute myeloid leukemia.
Iijima-Yamashita Y; Matsuo H; Yamada M; Deguchi T; Kiyokawa N; Shimada A; Tawa A; Takahashi H; Tomizawa D; Taga T; Kinoshita A; Adachi S; Horibe K
Pediatr Int; 2018 Jan; 60(1):47-51. PubMed ID: 29105243
[TBL] [Abstract][Full Text] [Related]
28. FUS-ERG induces late-onset azacitidine resistance in acute myeloid leukaemia cells.
Asai-Nishishita A; Kawahara M; Tatsumi G; Iwasa M; Fujishiro A; Nishimura R; Minamiguchi H; Kito K; Murata M; Andoh A
Sci Rep; 2023 Sep; 13(1):14454. PubMed ID: 37660196
[TBL] [Abstract][Full Text] [Related]
29. The RTK-RAS signaling pathway is enriched in patients with rare acute myeloid leukemia harboring t(16;21)(p11;q22)/
Lai A; Liu W; Wei H; Wang Y; Lin D; Zhou C; Liu B; Gu R; Li Y; Wei S; Gong B; Liu K; Gong X; Liu Y; Zhang G; Zhang J; Mi Y; Wang J; Qiu S
Blood Sci; 2024 Apr; 6(2):e00188. PubMed ID: 38742238
[TBL] [Abstract][Full Text] [Related]
30. CD66c (KOR-SA3544) antigen expression of leukemic blasts in pediatric acute myeloid leukemia with TLS/FUS-ERG fusion transcript.
Kobayashi K; Isobe K; Hanada R; Kawaguchi H; Iwata T; Kawamura M
Int J Lab Hematol; 2017 Dec; 39(6):e147-e150. PubMed ID: 28766906
[No Abstract] [Full Text] [Related]
31. Two distinct FUS breakpoint clusters in myxoid liposarcoma and acute myeloid leukemia with the translocations t(12;16) and t(16;21).
Panagopoulos I; Mandahl N; Mitelman F; Aman P
Oncogene; 1995 Sep; 11(6):1133-7. PubMed ID: 7566973
[TBL] [Abstract][Full Text] [Related]
32. BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
Zhang J; Shi J; Zhang G; Zhang X; Yang X; Yang S; Wang J; Ke X; Fu L
Ann Hematol; 2018 Aug; 97(8):1391-1397. PubMed ID: 29696374
[TBL] [Abstract][Full Text] [Related]
33. TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins.
Yang L; Embree LJ; Hickstein DD
Mol Cell Biol; 2000 May; 20(10):3345-54. PubMed ID: 10779324
[TBL] [Abstract][Full Text] [Related]
34. Identification of the characteristics and prognostic impact of FUS::ERG and RUNX1::CBFA2T3 fusion genes in adult acute myeloid leukemia patients.
Zhou Z; Zhuo N; Zhou Y; Sun C; Yao Y; Mao L; Zhang Y; Hong Q; Pan P; Tong H; Jin J; Wang H
Am J Hematol; 2024 Jul; 99(7):1441-1444. PubMed ID: 38651500
[No Abstract] [Full Text] [Related]
35. Novel high-risk acute myeloid leukemia subgroup with ERG amplification and Biallelic loss of TP53.
Schandl CA; Mazzoni S; Znoyko I; Nahhas GJ; Chung D; Ding Y; Hess B; Wolff DJ
Cancer Genet; 2023 Apr; 272-273():23-28. PubMed ID: 36657266
[TBL] [Abstract][Full Text] [Related]
36. ETV6 rearrangements are recurrent in myeloid malignancies and are frequently associated with other genetic events.
Haferlach C; Bacher U; Schnittger S; Alpermann T; Zenger M; Kern W; Haferlach T
Genes Chromosomes Cancer; 2012 Apr; 51(4):328-37. PubMed ID: 22162288
[TBL] [Abstract][Full Text] [Related]
37. Donor-Derived CD123-Targeted CAR T Cell Serves as a RIC Regimen for Haploidentical Transplantation in a Patient With
Yao S; Jianlin C; Yarong L; Botao L; Qinghan W; Hongliang F; Lu Z; Hongmei N; Pin W; Hu C; Liangding H; Bin Z
Front Oncol; 2019; 9():1358. PubMed ID: 31850234
[No Abstract] [Full Text] [Related]
38. Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
Miyamura T; Kudo K; Tabuchi K; Ishida H; Tomizawa D; Adachi S; Goto H; Yoshida N; Inoue M; Koh K; Sasahara Y; Fujita N; Kakuda H; Noguchi M; Hiwatari M; Hashii Y; Kato K; Atsuta Y; Okamoto Y
Leuk Res; 2019 Dec; 87():106263. PubMed ID: 31707119
[TBL] [Abstract][Full Text] [Related]
39. All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16.
Dembitz V; Lalic H; Tomic B; Smoljo T; Batinic J; Dubravcic K; Batinic D; Bedalov A; Visnjic D
Int J Hematol; 2022 Jan; 115(1):43-53. PubMed ID: 34546543
[TBL] [Abstract][Full Text] [Related]
40. TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease.
Kanazawa T; Ogawa C; Taketani T; Taki T; Hayashi Y; Morikawa A
Leuk Lymphoma; 2005 Dec; 46(12):1833-5. PubMed ID: 16263589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
